Novel insights into pathogenic mechanisms of severe exacerbation-prone asthma and their impact on clinical management
Ann Allergy Asthma Immunol
.
2022 Dec;129(6):651-652.
doi: 10.1016/j.anai.2022.09.003.
Authors
Thomas Makin
1
,
Marc Breidenbaugh
1
,
Larry Borish
2
Affiliations
1
Asthma and Allergic Disease Center, University of Virginia Health System, Charlottesville, Virginia.
2
Asthma and Allergic Disease Center, University of Virginia Health System, Charlottesville, Virginia. Electronic address:
[email protected]
.
PMID:
36464389
DOI:
10.1016/j.anai.2022.09.003
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Asthma* / drug therapy
Humans
Grants and funding
U01 AI123337/AI/NIAID NIH HHS/United States
UG1 HL139126/HL/NHLBI NIH HHS/United States
R21 AI151496/AI/NIAID NIH HHS/United States
R21 AI151497/AI/NIAID NIH HHS/United States
R56 AI158519/AI/NIAID NIH HHS/United States